Simulect



Indications and Reactions:

Role Indications Reactions
Primary
Renal Transplant 69.7%
Liver Transplant 8.9%
Immunosuppression 4.6%
Hypertension 3.1%
Prophylaxis 2.6%
Renal And Pancreas Transplant 1.7%
Infection Prophylaxis 1.5%
Prophylaxis Against Transplant Rejection 1.1%
Prophylaxis Against Gastrointestinal Ulcer 1.0%
Bone Marrow Transplant 0.8%
Transplant 0.8%
Kidney Transplant Rejection 0.7%
Diabetes Mellitus 0.6%
Organ Transplant 0.5%
Hypoalbuminaemia 0.5%
Sedative Therapy 0.5%
Diarrhoea 0.4%
Heart Transplant 0.3%
Induction Of Anaesthesia 0.3%
Intestinal Transplant 0.3%
Kidney Transplant Rejection 11.9%
Pyrexia 8.2%
Urine Output Decreased 8.2%
Sepsis 7.8%
Respiratory Failure 6.2%
Thrombotic Microangiopathy 5.8%
White Blood Cell Count Increased 5.3%
Renal Failure 4.9%
Transplant Rejection 4.9%
Urinary Tract Infection 4.5%
Renal Tubular Disorder 4.1%
Renal Tubular Necrosis 4.1%
Renal Impairment 3.7%
Vomiting 3.7%
Cytomegalovirus Infection 2.9%
Surgery 2.9%
Thrombocytopenia 2.9%
Toxic Encephalopathy 2.9%
Hypertension 2.5%
Staphylococcal Infection 2.5%
Secondary
Renal Transplant 60.1%
Liver Transplant 7.5%
Hypertension 5.5%
Drug Use For Unknown Indication 4.4%
Immunosuppression 3.6%
Prophylaxis Against Transplant Rejection 3.4%
Prophylaxis 3.3%
Prophylaxis Against Graft Versus Host Disease 2.1%
Infection Prophylaxis 1.6%
Prophylaxis Against Gastrointestinal Ulcer 1.3%
Lung Transplant 1.1%
Product Used For Unknown Indication 1.0%
Hyperlipidaemia 0.8%
Bone Marrow Conditioning Regimen 0.7%
Thrombosis Prophylaxis 0.7%
Gastritis Prophylaxis 0.6%
Anaesthesia 0.6%
Renal And Pancreas Transplant 0.6%
Bone Marrow Transplant 0.6%
Kidney Transplant Rejection 0.6%
Kidney Transplant Rejection 11.1%
Sepsis 8.0%
Urine Output Decreased 7.7%
Pyrexia 7.4%
Systemic Inflammatory Response Syndrome 6.8%
Transplant Rejection 6.5%
Urinary Tract Infection 5.5%
Vomiting 5.5%
Wound Secretion 4.9%
Renal Failure 4.6%
Hypertension 4.3%
Renal Tubular Necrosis 4.3%
Renal Impairment 3.7%
Respiratory Failure 3.7%
Cytomegalovirus Infection 2.8%
Surgery 2.8%
Tracheobronchitis 2.8%
Upper Respiratory Tract Infection 2.8%
Neutrophil Count Decreased 2.5%
Pancytopenia 2.5%
Concomitant
Renal Transplant 46.4%
Prophylaxis Against Transplant Rejection 14.5%
Prophylaxis 4.6%
Drug Use For Unknown Indication 4.5%
Hypertension 3.9%
Product Used For Unknown Indication 3.8%
Liver Transplant 2.7%
Infection Prophylaxis 2.4%
Immunosuppression 2.2%
Type 1 Diabetes Mellitus 2.2%
Gastritis Prophylaxis 1.8%
Renal Hypertension 1.7%
Constipation 1.5%
Lung Transplant 1.5%
Renal Failure Chronic 1.4%
Renal And Pancreas Transplant 1.3%
Immunosuppressant Drug Therapy 1.3%
Hypercholesterolaemia 0.8%
Prophylaxis Against Gastrointestinal Ulcer 0.8%
Hyperlipidaemia 0.7%
Pyrexia 8.5%
Proteinuria 7.9%
Renal Impairment 6.3%
Thrombotic Microangiopathy 6.3%
White Blood Cell Count Decreased 6.3%
Vomiting 5.8%
Transplant Rejection 5.3%
Death 4.8%
Focal Segmental Glomerulosclerosis 4.8%
Loss Of Consciousness 4.8%
Diabetes Mellitus 4.2%
Kidney Transplant Rejection 4.2%
Sepsis 4.2%
Wound Drainage 4.2%
Wound Secretion 4.2%
Cytomegalovirus Infection 3.7%
Renal Tubular Disorder 3.7%
Renal Tubular Necrosis 3.7%
Urine Output Decreased 3.7%
Osteonecrosis 3.2%
Interacting
Renal Transplant 100.0%
Urinary Tract Infection 100.0%